Retraction Note: MiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1
J.-Y. Chen, L.-F. Xu, H.-L. Hu, Y.-Q. Wen, D. Chen, W.-H. Liu Department of Urology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China
The article “MiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1”, by J.-Y. Chen, L.-F. Xu, H.-L. Hu, Y.-Q. Wen, D. Chen, W.-H. Liu, published in Eur Rev Med Pharmacol Sci 2020; 24 (2): 639-646–DOI: 10.26355/eurrev_202001_20040–PMID: 32017004 has been retracted by the Editor in Chief.
Following some concerns raised on PubPeer regarding a possible overlap in Figure 2C, the journal has started an investigation to assess the validity of the results as well as possible figure manipulation.
The journal investigation revealed data and figure manipulation. For this reason, the Editor in Chief has decided to retract the manuscript.
The authors have been informed about the retraction but remained unresponsive.
This article has been retracted. The Publisher apologizes for any inconvenience this may cause.
Free PDF DownloadMiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
J.-Y. Chen, L.-F. Xu, H.-L. Hu, Y.-Q. Wen, D. Chen, W.-H. Liu
Retraction Note: MiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1
Eur Rev Med Pharmacol Sci
Year: 2024
Vol. 28 - N. 10
Pages: 3476-3476
DOI: 10.26355/eurrev_202405_36279